FibroGen Announces Completion of the Pamrevlumab Arm in Precision Promise, Pancreatic Cancer Action Network’s Phase 2/3 Adaptive Platform Trial for Metastatic Pancreatic Cancer

<p>Pamrevlumab has now completed Stage 2 of the tria</p>
<p>The post <a href="https://forextv.com/top-news/fibrogen-announces-completion-of-the-pamrevlumab-arm-in-precision-promise-pancreatic-cancer-action-networks-phase-2-3-adaptive-platform-trial-for-metastatic-pancreatic-cancer/">FibroGen Announces Completion of the Pamrevlumab Arm in Precision Promise, Pancreatic Cancer Action Network’s Phase 2/3 Adaptive Platform Trial for Metastatic Pancreatic Cancer</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>